Carrier Screening Market to be dominated by Rising Prevalence of Genetic Conditions through 2027
Growing prevalence of
genetic diseases, and rising emphasis on early detection and prevention to
drive the carrier screening market in the forecast period, 2023-2027.
According to TechSci Research report, “Carrier
Screening Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, 2017-2027”, the global carrier screening market is anticipated
to grow at a significant rate in the forecast period, 2023-2027. The increasing
awareness of carrier screening among the population, upcoming new and advanced
technologies in the field of genomics, and rising emphasis on early detection
and prevention are
the primary factors driving the demand for the global carrier screening market.
Heavy investments on research and developments activities by government, increasing
birth rate across the globe, rising focus on personalized medicine, growing
awareness of carrier screening among the population, increasing maternal age are
expected to influence the market demand. The rise in numerous releases and
approvals of new carrier screening tests is also a key factor for increasing
the growth of the carrier screening market, globally.
However, the lack of high complexity testing centers,
regulatory challenges in the field of carrier screening, and existing
diagnostic confidence on conventional screening methods may hamper the growth of
the market in the forecast period.
Browse over XX market
data Figures spread through 110 Pages and an in-depth TOC on "Carrier Screening Market"
The global carrier screening
market is segmented into type, screening type, technology, indication, end
user, and company.
Based on type, the market is
divided into expanded carrier screening and targeted cancer screening. The expanded carrier screening segment is
expected to hold the significant market share. This is attributed to the development
of genomic tools to aid in breeding decisions and the cost and time factors are
driving the growth of the segment.
Based on screening type, the market is
divided into prenatal carrier testing and preconception carrier screening. The prenatal carrier testing segment is expected to
hold the significant market share. This
is due to the increased maternal age and rising awareness among couples to
know the risks of passing genetic anomalies to the child.
Based
on technology, the market is divided into next generation sequencing,
polymerase chain reaction, microarrays, and others. The next generation sequencing segment is projected to hold the largest
share in the carrier screening market. This is ascribed to the rising demand
for technologies such as sequencing because it offers more accuracy than other
technologies.
Based
on indication, the market is divided into cystic fibrosis, down’s syndrome,
thalassemia, tay sachs disease, huntington’s disease, sickle cell anemia, and
others. The cystic fibrosis segment is projected to hold the largest share in
the carrier screening market.
Based
on end user, the market is divided into hospitals & clinics, reference
laboratories, and others. The
hospitals & clinics segment
is expected to hold the largest market share in the forecast period. This is
attributed to the growing risks of genetic disorders, Also, the low cost of the
machine is propelling the market growth, rapid
adoption of technologically advanced carrier screening methods in hospitals and
clinics and rising birth rate worldwide.
Major operating companies
operating in global carrier screening market are:
- Eurofins Scientific, Inc.
- Fulgent Genetics, Inc.
- CENTOGENE N.V.
- Invitae Corporation
- Illumina, Inc.
- Gene by Gene, Ltd.
- Laboratory Corporation of America
Holdings
- Natera, Inc.
- Myriad Genetics, Inc.
- Quest Diagnostics, Inc.
Download Free Sample Report
Customers can also
request for 10% free customization on this report.
“North America region dominates the
market in 2021 and is expected to maintain its dominance in the coming years
due to the presence of well-established healthcare systems. Also, the wide
access to advanced screening techniques, increasing awareness of using mass
genetic testing programs, presence of various key players, many advances in
genomic medicine, rising government support, and increasing emphasis on
development and research in the region, are expected to propel the global Carrier
Screening market growth till 2027” said Mr. Karan Chechi, Research Director
with TechSci Research, a research based global management consulting firm.
“Carrier Screening Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented
By Type (Expanded Carrier Screening v/s Targeted Cancer Screening), By
Screening Type (Prenatal Carrier Testing v/s Preconception Carrier Screening),
By Technology (Next Generation Sequencing, Polymerase Chain Reaction,
Microarrays, Others), By Indication (Cystic Fibrosis, Down’s Syndrome,
Thalassemia, Tay-Sachs Disease, Huntington’s Disease, Sickle Cell Anemia,
Others), By End User (Hospitals & Clinics, Reference Laboratories, Others),
By Company, and By Region”, has evaluated the future growth potential of global carrier
screening and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global carrier screening market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com